U.S. equity markets experienced a pronounced divergence in individual stock performance during the week, as healthcare and AI infrastructure-related companies attracted investor interest while software and semiconductor shares faced substantial selling pressure. The contrast highlights how corporate earnings expectations and sector-specific developments are increasingly influencing market leadership, even as the broader market reflects a more mixed investment environment.

Vertiv, Carvana and Quanta Services Lead the Weekly Gainers

Vertiv (VRT) recorded the strongest performance among the stocks highlighted, gaining 19.7% during the week. The company was followed by Carvana (CVNA), which advanced 18.1%, and Quanta Services (PWR), which gained 13.6%. Their performance placed infrastructure-related and consumer-focused businesses among the leading gainers in the supplied market overview.

Healthcare stocks also delivered notable gains. Eli Lilly (LLY) rose 11.3%, while Gilead Sciences (GILD) advanced 9.4%, indicating relative strength in pharmaceutical and biotechnology-related companies. Other notable performers included Royal Caribbean (RCL), up 11.1%, Synopsys (SNPS), up 8.7%, and KLA (KLAC), which gained 8.5%. Tesla (TSLA) also advanced 7.4%, according to the accompanying commentary.

The gains among infrastructure-related companies are particularly notable given continued investment in data centers, electricity systems and computing capacity. However, the weekly share-price movements alone do not establish whether the advances were driven by earnings surprises, revised guidance or broader sector demand.

Software and Semiconductor Stocks Experience Heavy Selling

The largest losses were concentrated in software, cybersecurity and semiconductor-related companies. ServiceNow (NOW) plunged 33.9%, making it the weakest performer in the supplied list. Fortinet (FTNT) and Intel (INTC) each declined 24.4%, while Twilio (TWLO) fell 21.7%.

Additional losses included Marvell Technology (MRVL), down 14.1%, and Datadog (DDOG), which declined 12.8%. The selling pressure followed a difficult earnings week for technology companies, according to the source. The scale of the declines suggests that investors were reassessing expectations across several areas of the technology industry, although the supplied data do not identify the specific earnings or guidance developments behind each company’s performance.

Such sharp corrections can reflect concerns about valuations, future revenue growth, profitability and the sustainability of technology spending. For software and semiconductor businesses, even relatively strong operating results may not be sufficient to support share prices when market expectations are particularly demanding.

Alphabet Weighs on Communication Services as Sector Leadership Shifts

Alphabet (GOOGL) declined 12.6%, making it one of the largest technology-related contributors to the week’s weakness. The Kobeissi Letter noted that the decline helped pull the communication services sector down approximately 7.0%. Robinhood (HOOD) also recorded a notable decline of 10.6%, adding to the mixed performance across financial technology and consumer-oriented businesses.

The contrasting performance between healthcare, infrastructure and technology companies illustrates the importance of sector composition in evaluating the broader equity market. While selected companies connected to AI infrastructure and healthcare advanced, software and semiconductor businesses experienced significant valuation pressure. This divergence suggests that investors were becoming more selective rather than uniformly increasing or reducing exposure across the market.

For investors in Israel and internationally, developments in U.S. technology stocks remain important because these companies carry substantial weight in global equity benchmarks and investment portfolios. Their performance can influence international market sentiment, particularly when earnings announcements trigger large changes in valuations.

Looking ahead, investors will monitor upcoming earnings reports, corporate guidance, AI infrastructure spending and developments in healthcare and semiconductor demand. The sustainability of the recent gains among infrastructure and pharmaceutical companies will depend on their operating performance, while software and chipmakers will face continued scrutiny over growth expectations and profitability. Whether the current divergence develops into a broader rotation in market leadership or remains a temporary earnings-driven adjustment will become clearer as additional corporate results and economic data emerge.